Report
Jake Strole
EUR 850.00 For Business Accounts Only

Morningstar | The Combination of CVS and Aetna Creates a Franchise Protected by a Narrow Economic Moat

CVS has spent the better part of the last decade positioning itself as a leader within healthcare services--the acquisitions of Caremark, Omnicare, and most recently Aetna have defined its strategic direction. The combination of the leading PBM, retail pharmacy, and a top managed care franchise form the three pillars that we think position the firm to better compete with a consolidating healthcare services sector over the next 10 years. The cost advantages and underlying network effects that support the firm's excess economic returns are only set to strengthen as the integration of Aetna continues over the coming year. We think cost and sales synergies will likely exceed initial expectations as the firm begins to serve its customers at a lower all-in cost than rivals, increasing the attractiveness of its combined medical and pharmaceutical benefits offering.That said, we think investors will be increasingly cautious in their evaluation of potential issues arising from the transaction. The high price paid, and significant debt incurred, increases the operational risks of an otherwise largely stable franchise, in our view. Following the write-down of Omnicare during 2018 due to poor financial performance, we think there's little room for error in ensuring the Aetna acquisition sees success. This complexity is accentuated by the increasing focus in Washington toward changing the current drug pricing paradigm, opening the door to potential market disruption at Caremark and the PBM industry at large.Finally, while we expect concerns around healthcare reform to pick up over the coming quarters as the 2020 election cycle begins to unfold, we believe the firm's economic moat will help protect against policy-driven volatility. We maintain that large-scale disruption is a low-probability event and think a more likely outcome would include private service providers to play a role in any policy solution to the nation's rising cost of healthcare.
Underlying
CVS Health Corporation

CVS Health is a health company. The company's segments are: Pharmacy Services, which provides a range of pharmacy benefit management solutions, including plan design offerings and administration, formulary management, and retail pharmacy network management services; Retail/Long-Term Care (LTC), which sells prescription drugs and general merchandise, including over-the-counter drugs, provides health care services through its MinuteClinic? walk-in medical clinics and conducts LTC pharmacy operations; and Health Care Benefits, which provides a range of voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans.

Provider
Morningstar
Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

Analysts
Jake Strole

Other Reports on these Companies
Other Reports from Morningstar

ResearchPool Subscriptions

Get the most out of your insights

Get in touch